Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2428-2434
Published online before print September 1, 2005, doi: 10.1161/01.ATV.0000184765.59207.f3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/11/2428    most recent
01.ATV.0000184765.59207.f3v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chakrabarti, S.
Right arrow Articles by Freedman, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chakrabarti, S.
Right arrow Articles by Freedman, J. E.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2428.)
© 2005 American Heart Association, Inc.


Thrombosis

CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates

Subrata Chakrabarti; Sonia Varghese; Olga Vitseva; Kahraman Tanriverdi; Jane E. Freedman

From the Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass.

Correspondence to Subrata Chakrabarti, Boston University School of Medicine, 715 Albany St, W507, Boston, MA 02118. E-mail subrata{at}bu.edu

Objective— Soluble CD40 ligand (sCD40L) has been recently implicated in the pathogenesis of atherosclerosis. Elevated levels of sCD40L in acute coronary syndrome patients suggests enhanced platelet function; however, the exact mechanism by which this occurs is unknown. In this study, we examined the effect of sCD40L on platelet function and reactive oxygen and nitrogen species (RONS) generation.

Methods and Results— Platelet stimulation in the presence of recombinant sCD40L (rsCD40L) led to enhanced generation of RONS as measured by DCFHDA oxidation and confocal microscopy. Incubation with rsCD40L led to enhanced platelet P-selectin expression, aggregation, and platelet-leukocyte conjugation. Platelets isolated from CD40L-deficient mice had decreased agonist-induced NO release as compared with wild-type mice. Incubation of platelets with rsCD40L enhanced stimulation-induced p38 MAP kinase and Akt phosphorylation.

Conclusion— Soluble CD40L enhances platelet activation, aggregation, and platelet-leukocyte conjugation, as well as increases stimulation-induced platelet release of RONS through activation of Akt and p38 MAP kinase signaling pathways. These data suggest that sCD40L regulates platelet-dependent inflammatory and thrombotic responses that contribute to the pathogenesis of atherothrombosis.

The role of sCD40L in platelet function and RONS formation was examined. Soluble CD40L enhances platelet activation, aggregation, and platelet-leukocyte conjugation, as well as increases stimulation-induced platelet release of RONS through activation of Akt and p38 MAP kinase signaling pathways. sCD40L influences platelet-dependent thrombotic and inflammatory responses contributing to atherothrombosis.


Key Words: platelets • reactive oxygen species • CD40 ligand • fluorescence




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Y. Stokes, L. Calahan, C. M. Hamric, J. M. Russell, and D. N. Granger
CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H689 - H697.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chen, H. Chai, X. Wang, J. Jiang, M. S. Jamaluddin, D. Liao, Y. Zhang, H. Wang, U. Bharadwaj, S. Zhang, et al.
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells
Blood, October 15, 2008; 112(8): 3205 - 3216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Li, J. M. Sanders, M. H. Bevard, Z. Sun, J. W. Chumley, E. V. Galkina, K. Ley, and I. J. Sarembock
CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury
Am. J. Pathol., April 1, 2008; 172(4): 1141 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. E. Freedman
Oxidative Stress and Platelets
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): s11 - s16.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Cangemi, L. Loffredo, R. Carnevale, L. Perri, M. P. Patrizi, V. Sanguigni, P. Pignatelli, and F. Violi
Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E
Eur. Heart J., January 1, 2008; 29(1): 54 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chakrabarti, P. Blair, and J. E. Freedman
CD40-40L Signaling in Vascular Inflammation
J. Biol. Chem., June 22, 2007; 282(25): 18307 - 18317.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. von Hundelshausen and C. Weber
Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease
Circ. Res., January 5, 2007; 100(1): 27 - 40.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Alessandri, P. Pignatelli, L. Loffredo, L. Lenti, M. Del Ben, R. Carnevale, A. Perrone, D. Ferro, F. Angelico, and F. Violi
Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia.
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2577 - 2578.
[Full Text] [PDF]